

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 4.69964277 |
| 2 | chondrocyte proliferation (GO:0035988) | 4.67815089 |
| 3 | substrate-dependent cell migration (GO:0006929) | 4.59523775 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.46672938 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.46672938 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.39834808 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.39834808 |
| 8 | negative regulation of fibrinolysis (GO:0051918) | 4.28658966 |
| 9 | ganglion development (GO:0061548) | 4.20566381 |
| 10 | protein carboxylation (GO:0018214) | 4.09880768 |
| 11 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.09880768 |
| 12 | negative regulation of chondrocyte differentiation (GO:0032331) | 4.07001466 |
| 13 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.95180874 |
| 14 | protein localization to endosome (GO:0036010) | 3.82991471 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.80650184 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 3.80029538 |
| 17 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.78508007 |
| 18 | regulation of fibrinolysis (GO:0051917) | 3.78256381 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 3.72485930 |
| 20 | bile acid biosynthetic process (GO:0006699) | 3.65505945 |
| 21 | regulation of cholesterol homeostasis (GO:2000188) | 3.58892149 |
| 22 | fibrinolysis (GO:0042730) | 3.58370271 |
| 23 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.51159063 |
| 24 | cysteine metabolic process (GO:0006534) | 3.49720502 |
| 25 | kynurenine metabolic process (GO:0070189) | 3.41198847 |
| 26 | fibroblast migration (GO:0010761) | 3.40918881 |
| 27 | plasma lipoprotein particle clearance (GO:0034381) | 3.40077430 |
| 28 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.39768365 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 3.38260594 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 3.38260594 |
| 31 | cellular glucuronidation (GO:0052695) | 3.37140118 |
| 32 | endodermal cell differentiation (GO:0035987) | 3.31566099 |
| 33 | muscle cell migration (GO:0014812) | 3.29353290 |
| 34 | tryptophan catabolic process (GO:0006569) | 3.28131274 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 3.28131274 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 3.28131274 |
| 37 | response to nitrosative stress (GO:0051409) | 3.27994652 |
| 38 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.27409537 |
| 39 | axon extension involved in axon guidance (GO:0048846) | 3.27409537 |
| 40 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.25843464 |
| 41 | urea cycle (GO:0000050) | 3.25623796 |
| 42 | urea metabolic process (GO:0019627) | 3.25623796 |
| 43 | glyoxylate metabolic process (GO:0046487) | 3.24200691 |
| 44 | regulation of plasminogen activation (GO:0010755) | 3.22586937 |
| 45 | regulation of protein activation cascade (GO:2000257) | 3.20078705 |
| 46 | cell-substrate junction assembly (GO:0007044) | 3.18728998 |
| 47 | sulfur amino acid catabolic process (GO:0000098) | 3.17152236 |
| 48 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.16974201 |
| 49 | high-density lipoprotein particle remodeling (GO:0034375) | 3.15641175 |
| 50 | skin morphogenesis (GO:0043589) | 3.15382223 |
| 51 | response to gravity (GO:0009629) | 3.14725853 |
| 52 | Notch signaling involved in heart development (GO:0061314) | 3.14383675 |
| 53 | tryptophan metabolic process (GO:0006568) | 3.14367114 |
| 54 | complement activation, alternative pathway (GO:0006957) | 3.14090588 |
| 55 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.11509816 |
| 56 | glucuronate metabolic process (GO:0019585) | 3.09176202 |
| 57 | uronic acid metabolic process (GO:0006063) | 3.09176202 |
| 58 | hemidesmosome assembly (GO:0031581) | 3.08477601 |
| 59 | epoxygenase P450 pathway (GO:0019373) | 3.03621343 |
| 60 | pattern specification involved in kidney development (GO:0061004) | 3.02709887 |
| 61 | atrioventricular valve morphogenesis (GO:0003181) | 3.02510298 |
| 62 | regulation of triglyceride catabolic process (GO:0010896) | 3.00960843 |
| 63 | regulation of complement activation (GO:0030449) | 3.00655188 |
| 64 | semaphorin-plexin signaling pathway (GO:0071526) | 3.00380011 |
| 65 | hypotonic response (GO:0006971) | 2.99650317 |
| 66 | tyrosine metabolic process (GO:0006570) | 2.97693576 |
| 67 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.97645652 |
| 68 | positive regulation of lipid catabolic process (GO:0050996) | 2.97386054 |
| 69 | bile acid metabolic process (GO:0008206) | 2.96322420 |
| 70 | nitrogen cycle metabolic process (GO:0071941) | 2.96230835 |
| 71 | mesodermal cell differentiation (GO:0048333) | 2.95187906 |
| 72 | opsonization (GO:0008228) | 2.94068407 |
| 73 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.93428445 |
| 74 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.93345063 |
| 75 | mammary gland epithelial cell proliferation (GO:0033598) | 2.92545155 |
| 76 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.91963137 |
| 77 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.90942127 |
| 78 | negative regulation of cholesterol transport (GO:0032375) | 2.90880050 |
| 79 | negative regulation of sterol transport (GO:0032372) | 2.90880050 |
| 80 | positive regulation of astrocyte differentiation (GO:0048711) | 2.90072728 |
| 81 | keratinocyte proliferation (GO:0043616) | 2.89545459 |
| 82 | facial nerve structural organization (GO:0021612) | 2.87635274 |
| 83 | barbed-end actin filament capping (GO:0051016) | 2.86742493 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.86547967 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.86547967 |
| 86 | low-density lipoprotein particle clearance (GO:0034383) | 2.86016790 |
| 87 | cell adhesion mediated by integrin (GO:0033627) | 2.85959789 |
| 88 | negative regulation of catenin import into nucleus (GO:0035414) | 2.85604489 |
| 89 | positive regulation of osteoblast proliferation (GO:0033690) | 2.84129400 |
| 90 | positive regulation of blood coagulation (GO:0030194) | 2.80113728 |
| 91 | positive regulation of hemostasis (GO:1900048) | 2.80113728 |
| 92 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.79599931 |
| 93 | reverse cholesterol transport (GO:0043691) | 2.78890470 |
| 94 | acute-phase response (GO:0006953) | 2.78696993 |
| 95 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.78412284 |
| 96 | aromatic amino acid family metabolic process (GO:0009072) | 2.78331608 |
| 97 | triglyceride homeostasis (GO:0070328) | 2.78119347 |
| 98 | acylglycerol homeostasis (GO:0055090) | 2.78119347 |
| 99 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.77292858 |
| 100 | desmosome organization (GO:0002934) | 2.76926584 |
| 101 | type B pancreatic cell proliferation (GO:0044342) | 2.76901424 |
| 102 | hippo signaling (GO:0035329) | 2.76690911 |
| 103 | lung vasculature development (GO:0060426) | 2.76566849 |
| 104 | negative regulation of axon guidance (GO:1902668) | 2.76422656 |
| 105 | negative regulation of stem cell proliferation (GO:2000647) | 2.75548707 |
| 106 | endothelial cell morphogenesis (GO:0001886) | 2.74275716 |
| 107 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.74143260 |
| 108 | craniofacial suture morphogenesis (GO:0097094) | 2.71646071 |
| 109 | membrane assembly (GO:0071709) | 2.71061337 |
| 110 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.70829749 |
| 111 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.70711410 |
| 112 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.70533916 |
| 113 | regulation of cholesterol esterification (GO:0010872) | 2.70132402 |
| 114 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.69404870 |
| 115 | wound healing, spreading of cells (GO:0044319) | 2.67628965 |
| 116 | regulation of keratinocyte proliferation (GO:0010837) | 2.66638103 |
| 117 | ethanol oxidation (GO:0006069) | 2.66587427 |
| 118 | positive regulation of extracellular matrix organization (GO:1903055) | 2.65836973 |
| 119 | cholesterol efflux (GO:0033344) | 2.65757092 |
| 120 | protein-lipid complex remodeling (GO:0034368) | 2.64549994 |
| 121 | macromolecular complex remodeling (GO:0034367) | 2.64549994 |
| 122 | plasma lipoprotein particle remodeling (GO:0034369) | 2.64549994 |
| 123 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.63601086 |
| 124 | negative regulation of cartilage development (GO:0061037) | 2.62719119 |
| 125 | mammary gland development (GO:0030879) | 2.62260617 |
| 126 | protein-lipid complex assembly (GO:0065005) | 2.61992687 |
| 127 | endocardial cushion development (GO:0003197) | 2.61782778 |
| 128 | axon extension (GO:0048675) | 2.59644369 |
| 129 | positive regulation of coagulation (GO:0050820) | 2.59491918 |
| 130 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.58439202 |
| 131 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.58349032 |
| 132 | endothelial cell chemotaxis (GO:0035767) | 2.57922605 |
| 133 | cellular response to vitamin D (GO:0071305) | 2.56541051 |
| 134 | plasma lipoprotein particle assembly (GO:0034377) | 2.55672416 |
| 135 | cholesterol homeostasis (GO:0042632) | 2.55271520 |
| 136 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.55255895 |
| 137 | sterol homeostasis (GO:0055092) | 2.54397991 |
| 138 | kidney mesenchyme development (GO:0072074) | 2.53855394 |
| 139 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.53806049 |
| 140 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.52450386 |
| 141 | negative regulation of blood coagulation (GO:0030195) | 2.52401310 |
| 142 | negative regulation of hemostasis (GO:1900047) | 2.52401310 |
| 143 | positive regulation of p38MAPK cascade (GO:1900745) | 2.52349862 |
| 144 | endothelial tube morphogenesis (GO:0061154) | 2.51986435 |
| 145 | morphogenesis of an endothelium (GO:0003159) | 2.51986435 |
| 146 | negative regulation of fatty acid transport (GO:2000192) | 2.51755998 |
| 147 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.51509856 |
| 148 | cofactor catabolic process (GO:0051187) | 2.51336919 |
| 149 | arginine metabolic process (GO:0006525) | 2.50902004 |
| 150 | regulation of axon guidance (GO:1902667) | 2.50568512 |
| 151 | glutamate metabolic process (GO:0006536) | 2.50015630 |
| 152 | aldehyde catabolic process (GO:0046185) | 2.49997450 |
| 153 | coenzyme catabolic process (GO:0009109) | 2.49522525 |
| 154 | response to laminar fluid shear stress (GO:0034616) | 2.49343866 |
| 155 | negative regulation of anoikis (GO:2000811) | 2.48927140 |
| 156 | positive regulation of actin filament depolymerization (GO:0030836) | 2.48489861 |
| 157 | phospholipid efflux (GO:0033700) | 2.48435759 |
| 158 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.48374520 |
| 159 | negative regulation of lipase activity (GO:0060192) | 2.47214869 |
| 160 | glomerular visceral epithelial cell development (GO:0072015) | 2.46457620 |
| 161 | wound healing, spreading of epidermal cells (GO:0035313) | 2.45354674 |
| 162 | positive regulation of axon extension (GO:0045773) | 2.45096787 |
| 163 | presynaptic membrane assembly (GO:0097105) | 2.44890240 |
| 164 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.44884762 |
| 165 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.44521741 |
| 166 | lipoprotein metabolic process (GO:0042157) | 2.44438232 |
| 167 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.42692916 |
| 168 | cochlea morphogenesis (GO:0090103) | 2.42252159 |
| 169 | branch elongation of an epithelium (GO:0060602) | 2.42159750 |
| 170 | basement membrane organization (GO:0071711) | 2.40579649 |
| 171 | protein localization to microtubule (GO:0035372) | 2.39443432 |
| 172 | SMAD protein complex assembly (GO:0007183) | 2.37844799 |
| 173 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.37067636 |
| 174 | positive regulation of male gonad development (GO:2000020) | 2.37052179 |
| 175 | neuron projection extension (GO:1990138) | 2.35542045 |
| 176 | membrane raft organization (GO:0031579) | 2.35179487 |
| 177 | notochord development (GO:0030903) | 2.34383762 |
| 178 | cellular response to vitamin (GO:0071295) | 2.33254032 |
| 179 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.32540160 |
| 180 | anatomical structure arrangement (GO:0048532) | 2.32423880 |
| 181 | nephron tubule formation (GO:0072079) | 2.31428411 |
| 182 | neural crest cell development (GO:0014032) | 2.31144259 |
| 183 | cell proliferation involved in kidney development (GO:0072111) | 2.30647319 |
| 184 | regulation of positive chemotaxis (GO:0050926) | 2.30396204 |
| 185 | wound healing (GO:0042060) | 2.29745966 |
| 186 | protein hydroxylation (GO:0018126) | 2.29304826 |
| 187 | positive regulation of positive chemotaxis (GO:0050927) | 2.28567997 |
| 188 | regulation of gonadotropin secretion (GO:0032276) | 2.28407098 |
| 189 | smooth muscle tissue development (GO:0048745) | 2.27520446 |
| 190 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.25626086 |
| 191 | cranial nerve structural organization (GO:0021604) | 2.24153297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.97663424 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.71553039 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.46751146 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.97696790 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.92660630 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.74206748 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.44927004 |
| 8 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.43832385 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.38036373 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.97261217 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.63385157 |
| 12 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.62721804 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.58215363 |
| 14 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.55147356 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.53092931 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.44769982 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.28540597 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.27834707 |
| 19 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.25836047 |
| 20 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.08656201 |
| 21 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.07372730 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.04820344 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.99201324 |
| 24 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.98329168 |
| 25 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.89131915 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.86673255 |
| 27 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.84904881 |
| 28 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.81331810 |
| 29 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.76563042 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.72000643 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.69121343 |
| 32 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.68334195 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.66480683 |
| 34 | TP53_16413492_ChIP-PET_HCT116_Human | 1.66433342 |
| 35 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.66329410 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.65425506 |
| 37 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.62360807 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.58773559 |
| 39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.58496778 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.58397065 |
| 41 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.55963320 |
| 42 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.52446802 |
| 43 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50010026 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48643427 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48351880 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48249438 |
| 47 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47376075 |
| 48 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.46356065 |
| 49 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.46332072 |
| 50 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.43911101 |
| 51 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.43911101 |
| 52 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.43129811 |
| 53 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.43129811 |
| 54 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42673795 |
| 55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.41702146 |
| 56 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41551107 |
| 57 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.40609268 |
| 58 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.37485942 |
| 59 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36981148 |
| 60 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36430665 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32482230 |
| 62 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.30748865 |
| 63 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.29921419 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28506849 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28380808 |
| 66 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24590671 |
| 67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23010309 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21927909 |
| 69 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.20754212 |
| 70 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20244824 |
| 71 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19992761 |
| 72 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.19354637 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19129145 |
| 74 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18901486 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18517625 |
| 76 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.18221956 |
| 77 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17775027 |
| 78 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17119012 |
| 79 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.16575723 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16571243 |
| 81 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15661678 |
| 82 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15458548 |
| 83 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14723990 |
| 84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.14685545 |
| 85 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14088959 |
| 86 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.13796663 |
| 87 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13012575 |
| 88 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.12327383 |
| 89 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.11837463 |
| 90 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10597532 |
| 91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09909606 |
| 92 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09387218 |
| 93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08849807 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.08451078 |
| 95 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.08328366 |
| 96 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07622273 |
| 97 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06935064 |
| 98 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.06686083 |
| 99 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06633442 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06621652 |
| 101 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06405314 |
| 102 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05825921 |
| 103 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05707546 |
| 104 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04575342 |
| 105 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03913482 |
| 106 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03368326 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02568291 |
| 108 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01014245 |
| 109 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00154968 |
| 110 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99529477 |
| 111 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.99204841 |
| 112 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98788601 |
| 113 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96965252 |
| 114 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.95238563 |
| 115 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94778205 |
| 116 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94778205 |
| 117 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93745414 |
| 118 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92290443 |
| 119 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.92188527 |
| 120 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91981829 |
| 121 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90737950 |
| 122 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90417934 |
| 123 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90316662 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90282830 |
| 125 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89491196 |
| 126 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89137837 |
| 127 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88926083 |
| 128 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87753389 |
| 129 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.86432299 |
| 130 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.85873390 |
| 131 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85325735 |
| 132 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.84344356 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84085181 |
| 134 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.83574910 |
| 135 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82661392 |
| 136 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.82466374 |
| 137 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82277589 |
| 138 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81987482 |
| 139 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.81643179 |
| 140 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81407173 |
| 141 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.81337629 |
| 142 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.80134405 |
| 143 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.79931531 |
| 144 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78726840 |
| 145 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.77913894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.74757339 |
| 2 | MP0005360_urolithiasis | 4.12987415 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.58760010 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 3.16380670 |
| 5 | MP0005365_abnormal_bile_salt | 3.03716092 |
| 6 | MP0009840_abnormal_foam_cell | 2.92078951 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.88606113 |
| 8 | MP0005083_abnormal_biliary_tract | 2.78228942 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.68071633 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.55305732 |
| 11 | MP0002089_abnormal_postnatal_growth/wei | 2.38254515 |
| 12 | MP0004272_abnormal_basement_membrane | 2.32351831 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.20704206 |
| 14 | MP0000534_abnormal_ureter_morphology | 2.11331256 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.05104532 |
| 16 | MP0003195_calcinosis | 2.03618345 |
| 17 | MP0003252_abnormal_bile_duct | 2.01654645 |
| 18 | MP0010368_abnormal_lymphatic_system | 1.85939123 |
| 19 | MP0003941_abnormal_skin_development | 1.84011852 |
| 20 | MP0005409_darkened_coat_color | 1.83519681 |
| 21 | MP0005275_abnormal_skin_tensile | 1.80841860 |
| 22 | MP0003303_peritoneal_inflammation | 1.77453514 |
| 23 | MP0009384_cardiac_valve_regurgitation | 1.72268013 |
| 24 | MP0003453_abnormal_keratinocyte_physiol | 1.70599917 |
| 25 | MP0005023_abnormal_wound_healing | 1.70176774 |
| 26 | MP0001299_abnormal_eye_distance/ | 1.67897312 |
| 27 | MP0003385_abnormal_body_wall | 1.65823002 |
| 28 | MP0003755_abnormal_palate_morphology | 1.65816578 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.62256475 |
| 30 | MP0000751_myopathy | 1.56952579 |
| 31 | MP0000467_abnormal_esophagus_morphology | 1.54124684 |
| 32 | MP0000516_abnormal_urinary_system | 1.48579106 |
| 33 | MP0005367_renal/urinary_system_phenotyp | 1.48579106 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.45037090 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.44596117 |
| 36 | MP0005332_abnormal_amino_acid | 1.41309663 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.40874614 |
| 38 | MP0005623_abnormal_meninges_morphology | 1.39440096 |
| 39 | MP0000609_abnormal_liver_physiology | 1.38176055 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.36039338 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.35985770 |
| 42 | MP0005248_abnormal_Harderian_gland | 1.34861036 |
| 43 | MP0003724_increased_susceptibility_to | 1.33787587 |
| 44 | MP0005451_abnormal_body_composition | 1.32282323 |
| 45 | MP0001958_emphysema | 1.31982464 |
| 46 | MP0003091_abnormal_cell_migration | 1.31647945 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.31238850 |
| 48 | MP0010030_abnormal_orbit_morphology | 1.31230126 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.31217224 |
| 50 | MP0009053_abnormal_anal_canal | 1.29263827 |
| 51 | MP0000750_abnormal_muscle_regeneration | 1.29075206 |
| 52 | MP0002060_abnormal_skin_morphology | 1.28432145 |
| 53 | MP0002295_abnormal_pulmonary_circulatio | 1.28291608 |
| 54 | MP0006054_spinal_hemorrhage | 1.28130275 |
| 55 | MP0003279_aneurysm | 1.23850573 |
| 56 | MP0005257_abnormal_intraocular_pressure | 1.20713865 |
| 57 | MP0001881_abnormal_mammary_gland | 1.20143523 |
| 58 | MP0003935_abnormal_craniofacial_develop | 1.19492305 |
| 59 | MP0000432_abnormal_head_morphology | 1.17413337 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.17217245 |
| 61 | MP0002234_abnormal_pharynx_morphology | 1.15776549 |
| 62 | MP0003315_abnormal_perineum_morphology | 1.13341383 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.12688322 |
| 64 | MP0005164_abnormal_response_to | 1.12456810 |
| 65 | MP0008004_abnormal_stomach_pH | 1.12351093 |
| 66 | MP0002282_abnormal_trachea_morphology | 1.11557964 |
| 67 | MP0002177_abnormal_outer_ear | 1.10991592 |
| 68 | MP0002796_impaired_skin_barrier | 1.10733440 |
| 69 | MP0003436_decreased_susceptibility_to | 1.09778792 |
| 70 | MP0005503_abnormal_tendon_morphology | 1.09154772 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 1.08534255 |
| 72 | MP0003115_abnormal_respiratory_system | 1.08320353 |
| 73 | MP0000778_abnormal_nervous_system | 1.05723085 |
| 74 | MP0002254_reproductive_system_inflammat | 1.05631888 |
| 75 | MP0005171_absent_coat_pigmentation | 1.05124104 |
| 76 | MP0005408_hypopigmentation | 1.04501451 |
| 77 | MP0009764_decreased_sensitivity_to | 1.03149105 |
| 78 | MP0005501_abnormal_skin_physiology | 1.02177177 |
| 79 | MP0002233_abnormal_nose_morphology | 1.01804999 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 1.01646354 |
| 81 | MP0010771_integument_phenotype | 1.01630983 |
| 82 | MP0000762_abnormal_tongue_morphology | 1.01243551 |
| 83 | MP0003937_abnormal_limbs/digits/tail_de | 1.01224934 |
| 84 | MP0001915_intracranial_hemorrhage | 1.01035424 |
| 85 | MP0003942_abnormal_urinary_system | 1.00468133 |
| 86 | MP0004510_myositis | 1.00228762 |
| 87 | MP0000428_abnormal_craniofacial_morphol | 0.99919229 |
| 88 | MP0002697_abnormal_eye_size | 0.99358767 |
| 89 | MP0000733_abnormal_muscle_development | 0.98591655 |
| 90 | MP0000647_abnormal_sebaceous_gland | 0.98084696 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.97547833 |
| 92 | MP0001243_abnormal_dermal_layer | 0.96876781 |
| 93 | MP0005193_abnormal_anterior_eye | 0.95403033 |
| 94 | MP0004858_abnormal_nervous_system | 0.94329988 |
| 95 | MP0004947_skin_inflammation | 0.94269409 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.93330630 |
| 97 | MP0002933_joint_inflammation | 0.92494638 |
| 98 | MP0002098_abnormal_vibrissa_morphology | 0.90532853 |
| 99 | MP0002925_abnormal_cardiovascular_devel | 0.89550300 |
| 100 | MP0000383_abnormal_hair_follicle | 0.88812706 |
| 101 | MP0005165_increased_susceptibility_to | 0.87725346 |
| 102 | MP0001533_abnormal_skeleton_physiology | 0.87000881 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.86899166 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 0.86311017 |
| 105 | MP0002896_abnormal_bone_mineralization | 0.85714222 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.85673747 |
| 107 | MP0000249_abnormal_blood_vessel | 0.85553964 |
| 108 | MP0001542_abnormal_bone_strength | 0.85512951 |
| 109 | MP0003890_abnormal_embryonic-extraembry | 0.85237511 |
| 110 | MP0005508_abnormal_skeleton_morphology | 0.84633657 |
| 111 | MP0000537_abnormal_urethra_morphology | 0.83594587 |
| 112 | MP0002116_abnormal_craniofacial_bone | 0.83148408 |
| 113 | MP0001879_abnormal_lymphatic_vessel | 0.83104395 |
| 114 | MP0000462_abnormal_digestive_system | 0.82564018 |
| 115 | MP0002092_abnormal_eye_morphology | 0.82204163 |
| 116 | MP0001614_abnormal_blood_vessel | 0.82086280 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.81335558 |
| 118 | MP0001286_abnormal_eye_development | 0.79982247 |
| 119 | MP0000579_abnormal_nail_morphology | 0.79965615 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.78287469 |
| 121 | MP0000604_amyloidosis | 0.77825500 |
| 122 | MP0004883_abnormal_blood_vessel | 0.77213595 |
| 123 | MP0000598_abnormal_liver_morphology | 0.76794940 |
| 124 | MP0005166_decreased_susceptibility_to | 0.76489358 |
| 125 | MP0000749_muscle_degeneration | 0.76432065 |
| 126 | MP0001216_abnormal_epidermal_layer | 0.75468445 |
| 127 | MP0000627_abnormal_mammary_gland | 0.75210525 |
| 128 | MP0005187_abnormal_penis_morphology | 0.75091143 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.74944562 |
| 130 | MP0000566_synostosis | 0.74251904 |
| 131 | MP0002109_abnormal_limb_morphology | 0.73869625 |
| 132 | MP0003634_abnormal_glial_cell | 0.73724421 |
| 133 | MP0001849_ear_inflammation | 0.73689147 |
| 134 | MP0002932_abnormal_joint_morphology | 0.73240539 |
| 135 | MP0000163_abnormal_cartilage_morphology | 0.73163439 |
| 136 | MP0000920_abnormal_myelination | 0.73120995 |
| 137 | MP0003950_abnormal_plasma_membrane | 0.72790654 |
| 138 | MP0003329_amyloid_beta_deposits | 0.72485107 |
| 139 | MP0009643_abnormal_urine_homeostasis | 0.72356030 |
| 140 | MP0003075_altered_response_to | 0.72128412 |
| 141 | MP0005084_abnormal_gallbladder_morpholo | 0.71530342 |
| 142 | MP0004197_abnormal_fetal_growth/weight/ | 0.71183515 |
| 143 | MP0002168_other_aberrant_phenotype | 0.71131569 |
| 144 | MP0009250_abnormal_appendicular_skeleto | 0.71003028 |
| 145 | MP0005390_skeleton_phenotype | 0.70834971 |
| 146 | MP0002998_abnormal_bone_remodeling | 0.70672306 |
| 147 | MP0000858_altered_metastatic_potential | 0.70434544 |
| 148 | MP0005375_adipose_tissue_phenotype | 0.70222906 |
| 149 | MP0000343_altered_response_to | 0.69806985 |
| 150 | MP0001340_abnormal_eyelid_morphology | 0.69705326 |
| 151 | MP0002085_abnormal_embryonic_tissue | 0.69324030 |
| 152 | MP0003943_abnormal_hepatobiliary_system | 0.69199715 |
| 153 | MP0002133_abnormal_respiratory_system | 0.68153053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.51920208 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.78422666 |
| 3 | Xanthomatosis (HP:0000991) | 4.55838243 |
| 4 | Premature rupture of membranes (HP:0001788) | 4.41017648 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.30572671 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.29742055 |
| 7 | Atrophic scars (HP:0001075) | 3.87156436 |
| 8 | Arterial tortuosity (HP:0005116) | 3.78316249 |
| 9 | Protrusio acetabuli (HP:0003179) | 3.72450763 |
| 10 | Myocardial infarction (HP:0001658) | 3.57741129 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 3.54048997 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.37712090 |
| 13 | Vascular tortuosity (HP:0004948) | 3.34892984 |
| 14 | Peritonitis (HP:0002586) | 3.32389411 |
| 15 | Right ventricular cardiomyopathy (HP:0011663) | 3.29195631 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 3.23562708 |
| 17 | Vascular calcification (HP:0004934) | 3.18812863 |
| 18 | Follicular hyperkeratosis (HP:0007502) | 3.16658517 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14020382 |
| 20 | Cardiovascular calcification (HP:0011915) | 3.11586622 |
| 21 | Complement deficiency (HP:0004431) | 3.05905025 |
| 22 | Joint hemorrhage (HP:0005261) | 2.97932469 |
| 23 | Interstitial pulmonary disease (HP:0006530) | 2.96479641 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 2.94324824 |
| 25 | Ankle contracture (HP:0006466) | 2.92191943 |
| 26 | Shallow orbits (HP:0000586) | 2.83402699 |
| 27 | Hypolipoproteinemia (HP:0010981) | 2.81284579 |
| 28 | Esophageal varix (HP:0002040) | 2.80572118 |
| 29 | Natal tooth (HP:0000695) | 2.74969690 |
| 30 | Onycholysis (HP:0001806) | 2.74050504 |
| 31 | Abnormality of complement system (HP:0005339) | 2.71570226 |
| 32 | Ileus (HP:0002595) | 2.68420206 |
| 33 | Fat malabsorption (HP:0002630) | 2.67626161 |
| 34 | Hemorrhage of the eye (HP:0011885) | 2.66082226 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.65644760 |
| 36 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.64640411 |
| 37 | Milia (HP:0001056) | 2.63094934 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.61402385 |
| 39 | Upper limb muscle weakness (HP:0003484) | 2.60176366 |
| 40 | Epidermoid cyst (HP:0200040) | 2.59945620 |
| 41 | Turricephaly (HP:0000262) | 2.59334864 |
| 42 | Cervical subluxation (HP:0003308) | 2.47975363 |
| 43 | Microglossia (HP:0000171) | 2.43528159 |
| 44 | Axonal loss (HP:0003447) | 2.41086113 |
| 45 | Polycythemia (HP:0001901) | 2.34570751 |
| 46 | Neonatal short-limb short stature (HP:0008921) | 2.30394958 |
| 47 | Coronal craniosynostosis (HP:0004440) | 2.28687114 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.27858870 |
| 49 | Fragile skin (HP:0001030) | 2.27221015 |
| 50 | Nail dystrophy (HP:0008404) | 2.27028400 |
| 51 | Hypercholesterolemia (HP:0003124) | 2.26972871 |
| 52 | Fragile nails (HP:0001808) | 2.26418424 |
| 53 | Malnutrition (HP:0004395) | 2.25081674 |
| 54 | Insomnia (HP:0100785) | 2.23046225 |
| 55 | Plantar hyperkeratosis (HP:0007556) | 2.22459038 |
| 56 | Broad metatarsal (HP:0001783) | 2.22393045 |
| 57 | Small epiphyses (HP:0010585) | 2.21162288 |
| 58 | Upper limb amyotrophy (HP:0009129) | 2.21011667 |
| 59 | Distal upper limb amyotrophy (HP:0007149) | 2.21011667 |
| 60 | Abnormality of the Achilles tendon (HP:0005109) | 2.19786577 |
| 61 | Hypophosphatemic rickets (HP:0004912) | 2.17825624 |
| 62 | Deviation of the thumb (HP:0009603) | 2.17670515 |
| 63 | Focal segmental glomerulosclerosis (HP:0000097) | 2.17144735 |
| 64 | Respiratory distress (HP:0002098) | 2.16425133 |
| 65 | Hand muscle atrophy (HP:0009130) | 2.13780485 |
| 66 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13684234 |
| 67 | Bladder diverticulum (HP:0000015) | 2.13517744 |
| 68 | Amyloidosis (HP:0011034) | 2.13432778 |
| 69 | Bronchomalacia (HP:0002780) | 2.12454710 |
| 70 | Alopecia of scalp (HP:0002293) | 2.12432459 |
| 71 | Steatorrhea (HP:0002570) | 2.09566263 |
| 72 | Menorrhagia (HP:0000132) | 2.09278304 |
| 73 | Limb-girdle muscle atrophy (HP:0003797) | 2.09171513 |
| 74 | Blue sclerae (HP:0000592) | 2.07214002 |
| 75 | Infantile muscular hypotonia (HP:0008947) | 2.07172716 |
| 76 | Pterygium (HP:0001059) | 2.06960094 |
| 77 | Abnormal auditory evoked potentials (HP:0006958) | 2.06422019 |
| 78 | Mitral stenosis (HP:0001718) | 2.05868667 |
| 79 | Selective tooth agenesis (HP:0001592) | 2.05320616 |
| 80 | Aortic aneurysm (HP:0004942) | 2.04986499 |
| 81 | Mitral valve prolapse (HP:0001634) | 2.04894308 |
| 82 | Skin nodule (HP:0200036) | 2.03673862 |
| 83 | Generalized amyotrophy (HP:0003700) | 2.03430152 |
| 84 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03266531 |
| 85 | Syringomyelia (HP:0003396) | 2.01788281 |
| 86 | Spinal cord lesions (HP:0100561) | 2.01788281 |
| 87 | Elbow flexion contracture (HP:0002987) | 2.01687601 |
| 88 | Glomerulosclerosis (HP:0000096) | 2.01642867 |
| 89 | Hyperammonemia (HP:0001987) | 2.01203036 |
| 90 | Protruding ear (HP:0000411) | 2.00810134 |
| 91 | Wormian bones (HP:0002645) | 1.99595739 |
| 92 | Sparse lateral eyebrow (HP:0005338) | 1.99558748 |
| 93 | Aortic dissection (HP:0002647) | 1.98284953 |
| 94 | Increased connective tissue (HP:0009025) | 1.97256590 |
| 95 | Hepatocellular carcinoma (HP:0001402) | 1.96543223 |
| 96 | Vertebral arch anomaly (HP:0008438) | 1.96499519 |
| 97 | Tetraparesis (HP:0002273) | 1.95522426 |
| 98 | Spondylolisthesis (HP:0003302) | 1.92948892 |
| 99 | Abnormal hemoglobin (HP:0011902) | 1.92127535 |
| 100 | Increased serum ferritin (HP:0003281) | 1.91961950 |
| 101 | Cerebral aneurysm (HP:0004944) | 1.91754166 |
| 102 | Hyperacusis (HP:0010780) | 1.91498906 |
| 103 | Proximal placement of thumb (HP:0009623) | 1.91351541 |
| 104 | Arnold-Chiari malformation (HP:0002308) | 1.90964683 |
| 105 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90915405 |
| 106 | Parakeratosis (HP:0001036) | 1.88825948 |
| 107 | Thick nail (HP:0001805) | 1.88063943 |
| 108 | Osteolytic defects of the hand bones (HP:0009699) | 1.86199561 |
| 109 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86199561 |
| 110 | Abnormal cartilage morphology (HP:0002763) | 1.86110168 |
| 111 | Vertebral compression fractures (HP:0002953) | 1.85925594 |
| 112 | Abnormality of the umbilical cord (HP:0010881) | 1.85437543 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 1.84693402 |
| 114 | Achilles tendon contracture (HP:0001771) | 1.83541814 |
| 115 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.81641200 |
| 116 | Vertebral hypoplasia (HP:0008417) | 1.81641200 |
| 117 | Tibial bowing (HP:0002982) | 1.81376652 |
| 118 | Increased mean platelet volume (HP:0011877) | 1.80273801 |
| 119 | Abnormal delivery (HP:0001787) | 1.79787212 |
| 120 | Absent frontal sinuses (HP:0002688) | 1.79063966 |
| 121 | Cerebral inclusion bodies (HP:0100314) | 1.78781000 |
| 122 | Ankyloglossia (HP:0010296) | 1.78008387 |
| 123 | Hypoplasia of the iris (HP:0007676) | 1.76657286 |
| 124 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.76047275 |
| 125 | Abnormality of oral frenula (HP:0000190) | 1.75907925 |
| 126 | Rickets (HP:0002748) | 1.75895006 |
| 127 | Spastic diplegia (HP:0001264) | 1.75544223 |
| 128 | Ulnar bowing (HP:0003031) | 1.75500350 |
| 129 | Broad face (HP:0000283) | 1.75335548 |
| 130 | Soft skin (HP:0000977) | 1.75095425 |
| 131 | Advanced eruption of teeth (HP:0006288) | 1.74679767 |
| 132 | Entropion (HP:0000621) | 1.74641421 |
| 133 | Short nail (HP:0001799) | 1.74612925 |
| 134 | Limb-girdle muscle weakness (HP:0003325) | 1.74487906 |
| 135 | Hydroxyprolinuria (HP:0003080) | 1.74195670 |
| 136 | Abnormality of proline metabolism (HP:0010907) | 1.74195670 |
| 137 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.73844661 |
| 138 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.73844661 |
| 139 | Ectopia lentis (HP:0001083) | 1.73646318 |
| 140 | Aplasia cutis congenita (HP:0001057) | 1.73361213 |
| 141 | Protuberant abdomen (HP:0001538) | 1.72358288 |
| 142 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.71014622 |
| 143 | Single umbilical artery (HP:0001195) | 1.71014622 |
| 144 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.71014622 |
| 145 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70833842 |
| 146 | Back pain (HP:0003418) | 1.70565052 |
| 147 | Nephritis (HP:0000123) | 1.69608340 |
| 148 | Aneurysm (HP:0002617) | 1.69441349 |
| 149 | Spinal rigidity (HP:0003306) | 1.69220625 |
| 150 | Ketosis (HP:0001946) | 1.68395094 |
| 151 | Increased density of long bones (HP:0006392) | 1.67447203 |
| 152 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.66009822 |
| 153 | Aplasia of the phalanges of the hand (HP:0009802) | 1.66009822 |
| 154 | Aplasia involving bones of the extremities (HP:0009825) | 1.66009822 |
| 155 | Hypoglycemic coma (HP:0001325) | 1.65539580 |
| 156 | Abnormality of methionine metabolism (HP:0010901) | 1.63288445 |
| 157 | Conjugated hyperbilirubinemia (HP:0002908) | 1.62649758 |
| 158 | Flat acetabular roof (HP:0003180) | 1.62400775 |
| 159 | Adactyly (HP:0009776) | 1.61332859 |
| 160 | Short clavicles (HP:0000894) | 1.60732687 |
| 161 | Skull defect (HP:0001362) | 1.60228841 |
| 162 | Abnormality of dentin (HP:0010299) | 1.59282570 |
| 163 | Open mouth (HP:0000194) | 1.58712826 |
| 164 | Hypopigmentation of the fundus (HP:0007894) | 1.58341901 |
| 165 | Hydroureter (HP:0000072) | 1.57783033 |
| 166 | Abnormality of carpal bone ossification (HP:0006257) | 1.57684755 |
| 167 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.54931788 |
| 168 | Long toe (HP:0010511) | 1.52716673 |
| 169 | Palmar hyperkeratosis (HP:0010765) | 1.52627150 |
| 170 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.52226830 |
| 171 | Subacute progressive viral hepatitis (HP:0006572) | 1.52218994 |
| 172 | Shoulder girdle muscle weakness (HP:0003547) | 1.51764325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 4.42868841 |
| 2 | ERN1 | 3.74704028 |
| 3 | SIK1 | 3.36086081 |
| 4 | EPHB1 | 3.30431011 |
| 5 | LMTK2 | 2.99121568 |
| 6 | NTRK1 | 2.56476313 |
| 7 | TRIB3 | 2.43521530 |
| 8 | MKNK2 | 2.33575977 |
| 9 | STK39 | 2.30249827 |
| 10 | MST1R | 2.12503749 |
| 11 | BMX | 2.11555986 |
| 12 | LATS1 | 2.06498734 |
| 13 | FGFR4 | 1.97165520 |
| 14 | EPHB2 | 1.92289511 |
| 15 | MET | 1.92169292 |
| 16 | ERBB3 | 1.87979918 |
| 17 | EPHA3 | 1.83083441 |
| 18 | ERBB4 | 1.78475796 |
| 19 | FER | 1.70822793 |
| 20 | LATS2 | 1.70657506 |
| 21 | PTK6 | 1.65881630 |
| 22 | PIM2 | 1.64305571 |
| 23 | WEE1 | 1.63159322 |
| 24 | DDR2 | 1.61640566 |
| 25 | PTK2 | 1.52741913 |
| 26 | MST4 | 1.50390396 |
| 27 | MAP3K3 | 1.41267316 |
| 28 | WNK4 | 1.38623060 |
| 29 | STK38L | 1.37458933 |
| 30 | BUB1 | 1.35187426 |
| 31 | PKN2 | 1.34184619 |
| 32 | DYRK1B | 1.30459864 |
| 33 | TAOK2 | 1.28975719 |
| 34 | LRRK2 | 1.27408928 |
| 35 | MAP3K12 | 1.27277787 |
| 36 | TBK1 | 1.25514530 |
| 37 | NME2 | 1.25276490 |
| 38 | PAK2 | 1.25133865 |
| 39 | MAP2K2 | 1.22038137 |
| 40 | TTN | 1.16015809 |
| 41 | FLT3 | 1.12853316 |
| 42 | DMPK | 1.12695682 |
| 43 | SIK3 | 1.09764763 |
| 44 | MARK1 | 1.09669031 |
| 45 | PIK3CA | 1.09472047 |
| 46 | TAOK1 | 1.09163692 |
| 47 | KDR | 1.08103743 |
| 48 | TRIM28 | 1.07731807 |
| 49 | RIPK1 | 1.06653404 |
| 50 | ABL2 | 1.06281562 |
| 51 | ERBB2 | 1.05167080 |
| 52 | LIMK1 | 1.03753305 |
| 53 | MAPK15 | 1.02057323 |
| 54 | EPHA4 | 1.02014434 |
| 55 | AKT3 | 1.00499872 |
| 56 | PBK | 1.00029068 |
| 57 | CSK | 0.99760340 |
| 58 | PDGFRA | 0.98261596 |
| 59 | TESK2 | 0.97422037 |
| 60 | FGFR2 | 0.95885533 |
| 61 | MAP3K10 | 0.94153628 |
| 62 | CDK8 | 0.93633137 |
| 63 | EIF2AK1 | 0.92316266 |
| 64 | PNCK | 0.92196641 |
| 65 | MKNK1 | 0.92178510 |
| 66 | MAP3K11 | 0.91331618 |
| 67 | TESK1 | 0.91257675 |
| 68 | STK10 | 0.91114663 |
| 69 | PAK3 | 0.87373606 |
| 70 | MOS | 0.87362014 |
| 71 | ICK | 0.86405654 |
| 72 | TAOK3 | 0.85954502 |
| 73 | PAK4 | 0.85144478 |
| 74 | IRAK2 | 0.84233975 |
| 75 | NEK9 | 0.83156445 |
| 76 | CDK6 | 0.83122125 |
| 77 | STK3 | 0.82771608 |
| 78 | EIF2AK3 | 0.82650163 |
| 79 | PDGFRB | 0.82551645 |
| 80 | PRKG2 | 0.82185359 |
| 81 | ARAF | 0.81995441 |
| 82 | GSK3A | 0.81608162 |
| 83 | RPS6KA4 | 0.79880906 |
| 84 | BCKDK | 0.79710539 |
| 85 | TRPM7 | 0.78087577 |
| 86 | MAP3K14 | 0.77503259 |
| 87 | TGFBR1 | 0.75324578 |
| 88 | EIF2AK2 | 0.74504593 |
| 89 | PRKD1 | 0.73038749 |
| 90 | CHUK | 0.72454094 |
| 91 | KSR1 | 0.72203207 |
| 92 | CLK1 | 0.69478294 |
| 93 | ROCK2 | 0.69461971 |
| 94 | WNK1 | 0.69098937 |
| 95 | MTOR | 0.68082254 |
| 96 | NLK | 0.68034401 |
| 97 | PHKG1 | 0.66322240 |
| 98 | PHKG2 | 0.66322240 |
| 99 | BCR | 0.65367159 |
| 100 | ROCK1 | 0.64923930 |
| 101 | PTK2B | 0.64826261 |
| 102 | PLK2 | 0.64822639 |
| 103 | STK38 | 0.64359274 |
| 104 | DAPK3 | 0.63212634 |
| 105 | MAP3K1 | 0.62461828 |
| 106 | NEK1 | 0.61938661 |
| 107 | MAP2K1 | 0.61101663 |
| 108 | IRAK3 | 0.58052967 |
| 109 | MYLK | 0.57927778 |
| 110 | MELK | 0.57266451 |
| 111 | IRAK1 | 0.56788706 |
| 112 | ILK | 0.55995258 |
| 113 | PAK6 | 0.55713771 |
| 114 | SRPK1 | 0.54112643 |
| 115 | NUAK1 | 0.52015953 |
| 116 | CAMK1G | 0.51544761 |
| 117 | TGFBR2 | 0.47883244 |
| 118 | MAP3K2 | 0.45602994 |
| 119 | FGFR1 | 0.45513806 |
| 120 | CSNK1A1L | 0.45422358 |
| 121 | CAMK2D | 0.45366032 |
| 122 | IKBKB | 0.45232211 |
| 123 | PIK3CG | 0.45189375 |
| 124 | MAP3K9 | 0.44101372 |
| 125 | PRKD2 | 0.44016238 |
| 126 | INSR | 0.43907820 |
| 127 | MAP3K7 | 0.43450464 |
| 128 | PRKD3 | 0.42778493 |
| 129 | MATK | 0.41836759 |
| 130 | TIE1 | 0.41376656 |
| 131 | OXSR1 | 0.40524981 |
| 132 | EGFR | 0.40185869 |
| 133 | TNIK | 0.40142682 |
| 134 | ABL1 | 0.39704576 |
| 135 | JAK1 | 0.38288467 |
| 136 | CAMK2G | 0.37704777 |
| 137 | BMPR1B | 0.37596789 |
| 138 | MAP2K7 | 0.37102873 |
| 139 | MAPKAPK2 | 0.36663715 |
| 140 | IKBKE | 0.36438710 |
| 141 | MAP3K8 | 0.35058261 |
| 142 | BRD4 | 0.33495226 |
| 143 | ADRBK1 | 0.30508633 |
| 144 | BRSK1 | 0.30163383 |
| 145 | GRK7 | 0.29032800 |
| 146 | NEK2 | 0.28439679 |
| 147 | PRKCE | 0.28213805 |
| 148 | CDK18 | 0.27180800 |
| 149 | TSSK6 | 0.26866915 |
| 150 | PLK3 | 0.23818056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.90649802 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.08381377 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.76134455 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.66337985 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54074791 |
| 6 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.50912665 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.41661305 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.33913826 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10433655 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.02621975 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97646769 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96667755 |
| 13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93919778 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92620553 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88826847 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84742251 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.82726586 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82492639 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.81662361 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71768986 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71690160 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.66548452 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.60896679 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57789231 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.55290034 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52710541 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.51672180 |
| 28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.50887299 |
| 29 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.50557043 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47682081 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43369020 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43049144 |
| 33 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.41831956 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35574817 |
| 35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.35539008 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33470719 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.32937113 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29923157 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 1.26539204 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25488227 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.25321428 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.24206338 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22960206 |
| 44 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.20720675 |
| 45 | Melanoma_Homo sapiens_hsa05218 | 1.20165559 |
| 46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.19283117 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 1.15136906 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.13002898 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.12582036 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12151160 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.11088494 |
| 52 | Pathways in cancer_Homo sapiens_hsa05200 | 1.09480143 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07810823 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06522967 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06044958 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03826897 |
| 57 | Glioma_Homo sapiens_hsa05214 | 1.03678076 |
| 58 | Colorectal cancer_Homo sapiens_hsa05210 | 1.02893540 |
| 59 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.00803645 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00526147 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 1.00211609 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.97989124 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97342667 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.94433714 |
| 65 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.91097770 |
| 66 | Focal adhesion_Homo sapiens_hsa04510 | 0.90954471 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90837225 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89771479 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89434325 |
| 70 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.89024935 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.85792441 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85201930 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84835462 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.83645946 |
| 75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82607312 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82215146 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82153992 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81832341 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80367626 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80321366 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80028654 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79419505 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.78273418 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77759625 |
| 85 | Proteasome_Homo sapiens_hsa03050 | 0.76235064 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75689403 |
| 87 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75110106 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74840187 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71842059 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70143577 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70099811 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69946299 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.69822193 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69657748 |
| 95 | Gap junction_Homo sapiens_hsa04540 | 0.69141390 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.68630328 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67182274 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.66516878 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66428404 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.65957608 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.65023661 |
| 102 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60566255 |
| 103 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.60553088 |
| 104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60115278 |
| 105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59689084 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59587353 |
| 107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58920761 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.58043427 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57749663 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57116186 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56185235 |
| 112 | Hepatitis B_Homo sapiens_hsa05161 | 0.56056886 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55360837 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53618144 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53181533 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52662934 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51825112 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51409775 |
| 119 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50871736 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50214558 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.49646125 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49404304 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48853941 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48387976 |
| 125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.47515197 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47180308 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46763257 |
| 128 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46376438 |
| 129 | Leishmaniasis_Homo sapiens_hsa05140 | 0.46240032 |
| 130 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45121269 |
| 131 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43959331 |
| 132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43780211 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43711099 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43480032 |
| 135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42487110 |
| 136 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41888720 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.40956628 |
| 138 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40585058 |
| 139 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.40006081 |
| 140 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39378492 |
| 141 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39010493 |
| 142 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37983757 |
| 143 | Protein export_Homo sapiens_hsa03060 | 0.37913087 |
| 144 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37374454 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | 0.37207107 |
| 146 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.36802998 |
| 147 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36341348 |
| 148 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35476461 |
| 149 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.35221364 |
| 150 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34921538 |
| 151 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34853797 |
| 152 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34773026 |
| 153 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34426895 |
| 154 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.34033973 |
| 155 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34025914 |
| 156 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.33772845 |
| 157 | Prostate cancer_Homo sapiens_hsa05215 | 0.31961143 |
| 158 | Salmonella infection_Homo sapiens_hsa05132 | 0.31144529 |
| 159 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.30094271 |
| 160 | Hepatitis C_Homo sapiens_hsa05160 | 0.29991050 |
| 161 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29436010 |
| 162 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.29193188 |
| 163 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.28434715 |
| 164 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28295215 |
| 165 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.26623945 |

